BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33389369)

  • 1. Effect of antiglaucoma agents on short-term intraocular pressure fluctuations after intravitreal bevacizumab injections.
    Shoeibi N; Ghosi Z; Jafari H; Omidtabrizi A
    Int Ophthalmol; 2021 Mar; 41(3):1081-1090. PubMed ID: 33389369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prophylactic intraocular pressure-lowering medication on intraocular pressure spikes after intravitreal injections.
    Frenkel MP; Haji SA; Frenkel RE
    Arch Ophthalmol; 2010 Dec; 128(12):1523-7. PubMed ID: 21149773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of prophylactic treatment of intraocular pressure spikes due to intravitreal injections].
    El Chehab H; Le Corre A; Giraud JM; Ract-Madoux G; Swalduz B; Dot C
    J Fr Ophtalmol; 2012 Oct; 35(8):614-21. PubMed ID: 22832030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of topical pressure-lowering medication on prevention of intraocular pressure spikes after intravitreal injection.
    El Chehab H; Le Corre A; Agard E; Ract-Madoux G; Coste O; Dot C
    Eur J Ophthalmol; 2013; 23(3):277-83. PubMed ID: 23161177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypotensive efficacy of topical brimonidine for intraocular pressure spikes following intravitreal injections of antivascular endothelial growth factor agents: a randomised crossover trial.
    Felfeli T; Hostovsky A; Trussart R; Yan P; Brent MH; Mandelcorn ED
    Br J Ophthalmol; 2019 Oct; 103(10):1388-1394. PubMed ID: 30573499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of prophylactic medication and influence of vitreous reflux in pressure rise after intravitreal injections of anti-VEGF drugs.
    Carnota-Méndez P; Méndez-Vázquez C; Otero-Villar J; Saavedra-Pazos JA
    Eur J Ophthalmol; 2014; 24(5):771-7. PubMed ID: 24706353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EFFECT OF SERIAL ANTERIOR CHAMBER PARACENTESIS ON SUSTAINED INTRAOCULAR PRESSURE ELEVATION IN PATIENTS RECEIVING INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
    Sisk RA; Rusia D; Zamora BG; Kuley A; Toussaint BW
    Retina; 2019 Oct; 39(10):1959-1964. PubMed ID: 30234855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of prior glaucoma surgery on intraocular pressure immediately after anti-vascular endothelial growth factor injection.
    Lam J; Luttrell I; Ding L; Rezaei K; Chao JR; Chee Y; Olmos De Koo LC; Wen JC
    Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2489-2494. PubMed ID: 31388743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of prophylactic intraocular pressure-lowering medication (brinzolamide) on intraocular pressure after ranibizumab intravitreal injection: A case-control study.
    Song S; Yu XB; Dai H
    Indian J Ophthalmol; 2016 Oct; 64(10):762-766. PubMed ID: 27905340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic intraocular pressure lowering measures in anti-vascular endothelial growth factor therapy: A systematic review and meta-analysis.
    Arjmand P; Yu CW; Popovic MM; Jhaveri A; Mandelcorn ED
    Surv Ophthalmol; 2023; 68(3):425-445. PubMed ID: 36529267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained intraocular pressure elevation in eyes treated with intravitreal injections of anti-vascular endothelial growth factor for diabetic macular edema in a real-life setting.
    Vo Kim S; Fajnkuchen F; Sarda V; Qu-Knafo L; Bodaghi B; Giocanti-Aurégan A
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2165-2171. PubMed ID: 28831613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term intraocular pressure trends following intravitreal ranibizumab injections for neovascular age-related macular degeneration-the role of oral acetazolamide in protecting glaucoma patients.
    Murray CD; Wood D; Allgar V; Walters G; Gale RP
    Eye (Lond); 2014 Oct; 28(10):1218-22. PubMed ID: 25081290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The early effects of intravitreal anti vascular endothelial growth factor agents on intraocular pressure and central corneal thickness.
    Omay E; Elgin U; Sen E; Yilmazbas P
    Int Ophthalmol; 2016 Oct; 36(5):665-70. PubMed ID: 26780098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraocular Pressure Changes in Non-Glaucomatous Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Agents.
    Kiddee W; Montriwet M
    PLoS One; 2015; 10(9):e0137833. PubMed ID: 26360382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained elevated intraocular pressures after intravitreal injection of bevacizumab, ranibizumab, and pegaptanib.
    Choi DY; Ortube MC; McCannel CA; Sarraf D; Hubschman JP; McCannel TA; Gorin MB
    Retina; 2011 Jun; 31(6):1028-35. PubMed ID: 21836409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of intraocular pressure elevation following intravitreal injections].
    Budzinskaya MV; Shelankova AV; Andreeva YS
    Vestn Oftalmol; 2022; 138(5. Vyp. 2):240-246. PubMed ID: 36287162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated intravitreal anti-vascular endothelial growth factor injections can induce iatrogenic ocular hypertension, especially in patients with open-angle glaucoma.
    Agard E; Elchehab H; Ract-Madoux G; Russo A; Lagenaite C; Dot C
    Can J Ophthalmol; 2015 Apr; 50(2):127-31. PubMed ID: 25863852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraocular Pressure in Eyes Receiving Intravitreal Antivascular Endothelial Growth Factor Injections.
    Lemos V; Cabugueira A; Noronha M; Abegão Pinto L; Reina M; Branco J; Gomes T
    Ophthalmologica; 2015; 233(3-4):162-8. PubMed ID: 25791262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of ocular hypertension after intravitreal injection of anti-VEGF agents in the treatment of neovascular AMD.
    Moraru A; Pînzaru G; Moţoc A; Costin D; Brănişteanu D
    Rom J Ophthalmol; 2017; 61(3):207-211. PubMed ID: 29450400
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical predictors of sustained intraocular pressure elevation due to intravitreal anti-vascular endothelial growth factor therapy.
    Hoang QV; Tsuang AJ; Gelman R; Mendonca LS; Della Torre KE; Jung JJ; Freund KB
    Retina; 2013 Jan; 33(1):179-87. PubMed ID: 22990314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.